COMP <GO>
XPEL vs TMO // NET PROFIT MARGIN
XPEL Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: XPEL 7
— TMO 5
▲ NET PROFIT MARGIN LEADER: TMO
LAST: $45.78 (+4.35%) • MKT CAP: $1.26B
net-margins
10.80%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
net-margins
15.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XPEL VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XPEL | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.60% | 9.30% | +12.30 | XPEL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | 30.4x | -12.10 | XPEL | /valuation <GO> |
| Free Cash Flow Yield | 4.99% | 2.40% | +2.59 | XPEL | /fcf-yield <GO> |
| Operating Margin | 13.20% | 17.40% | -4.20 | TMO | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 10.80% | 15.10% | -4.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 13.30% | 3.90% | +9.40 | XPEL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.04 | 4.50 | +6.54 | XPEL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | XPEL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.4 | 62.9 | -7.50 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.7x | 36.3x | -15.60 | XPEL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.26B | $262.22B | -$260.96B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XPEL REV | TMO REV | XPEL GROSS % | TMO GROSS % | XPEL FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $476.2M | $44.56B | 42.2% | — | $62.9M | $6.29B |
| FY 2024 | $420.4M | $42.88B | 42.2% | — | $41.1M | $7.27B |
| FY 2023 | $396.3M | $42.86B | — | — | $37.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XPEL // BETA —
TMO // BETA 0.94